SomnoMed Limited (ASX:SOM)

SomnoMed Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	18.03	17.29	16.18	11.96	15.64	21.11
Cash & Short-Term Investments	18.03	17.29	16.18	11.96	15.64	21.11
Cash Growth	4.25%	6.89%	35.32%	-23.57%	-25.89%	-30.04%
Accounts Receivable	15.36	11.19	7.05	7.53	7.65	6.79
Other Receivables	-	2.91	1.19	1.5	1.56	1.43
Receivables	15.36	14.1	8.24	9.03	9.2	8.22
Inventory	7.6	7.43	6.29	4.1	3.09	2.33
Prepaid Expenses	2.79	4.32	4.43	2.41	2.38	2.46
Total Current Assets	43.78	43.14	35.14	27.5	30.32	34.13
Property, Plant & Equipment	12.65	13.91	11.15	12.73	9.12	10.34
Goodwill	6.9	7.05	6.34	6.49	6.04	6.26
Other Intangible Assets	1.25	1.56	2.12	2.81	2.79	1.07
Long-Term Accounts Receivable	0.05	0.06	0.06	0.04	0.26	0.08
Long-Term Deferred Tax Assets	1.75	2.38	3.14	3.25	2.95	3.04
Long-Term Deferred Charges	13.52	12.88	11.85	9.67	6.62	1.25
Total Assets	79.9	80.97	69.8	62.49	58.09	56.17

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	16.6	19.34	13.11	12	12.59	10.33
Accrued Expenses	-	3.62	2.51	1.95	2.17	1.96
Current Portion of Long-Term Debt	0.28	0.34	0.31	0.31	4.88	-
Current Portion of Leases	2.23	2.49	2.3	2.26	1.78	1.96
Current Income Taxes Payable	1.74	1.77	0.22	0.46	1.11	1.01
Current Unearned Revenue	-	-	-	0	0	0
Other Current Liabilities	4.01	1.02	1.51	1.38	1.25	0.94
Total Current Liabilities	24.86	28.58	19.94	18.36	23.77	16.2
Long-Term Debt	0.44	0.45	0.71	16.36	2.01	2.35
Long-Term Leases	3.67	4.74	3.41	4.59	3.34	4.6
Pension & Post-Retirement Benefits	0.9	0.81	0.72	0.79	1.18	0.85
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	29.86	34.58	24.78	40.09	30.31	24.01

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	112.2	119.96	119.96	84	84	84
Retained Earnings	-77.2	-77.94	-74.48	-62.24	-54.24	-49.8
Comprehensive Income & Other	15.03	4.37	-0.46	0.64	-1.98	-2.04
Total Common Equity	50.04	46.39	45.02	22.4	27.79	32.16
Shareholders' Equity	50.04	46.39	45.02	22.4	27.79	32.16
Total Liabilities & Equity	79.9	80.97	69.8	62.49	58.09	56.17

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	6.61	8.03	6.72	23.51	12.01	8.91
Net Cash (Debt)	11.42	9.27	9.46	-11.55	3.63	12.2
Net Cash Growth	23.17%	-2.02%	-	-	-70.22%	-16.68%
Net Cash Per Share	0.05	0.04	0.08	-0.15	0.05	0.16
Filing Date Shares Outstanding	218.18	216.11	216.11	99.08	82.76	82.76
Total Common Shares Outstanding	218.18	216.11	216.11	82.76	82.76	82.76
Working Capital	18.91	14.56	15.2	9.14	6.54	17.93
Book Value Per Share	0.23	0.21	0.21	0.27	0.34	0.39
Tangible Book Value	41.89	37.79	36.56	13.1	18.96	24.83
Tangible Book Value Per Share	0.19	0.17	0.17	0.16	0.23	0.30
Machinery	-	17.79	14.82	13.96	12.41	12.35
Leasehold Improvements	-	1.72	1.2	1.12	0.72	0.71

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 6, 2026

Data Sources Report a data error